Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi




http://scihub22266oqcxt.onion/
suck pdf from google scholar
21314017!3040592!21314017
unlimited free pdf from europmc21314017    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid21314017      Acta+Myol 2010 ; 29 (2): 343-50
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • State of the art in hereditary muscle channelopathies #MMPMID21314017
  • Jurkat-Rott K; Lehmann-Horn F
  • Acta Myol 2010[Oct]; 29 (2): 343-50 PMID21314017show ga
  • A combination of electrophysiological and genetic studies has resulted in the identification of several skeletal muscle disorders to be caused by pathologically functioning ion channels and has led to the term channelopathies. Typical hereditary muscle channelopa thies are congenital myasthenic syndromes, non-dystrophic myotonias, periodic paralyses, malignant hyperthermia, and central core disease. Most muscle channelopathies are commonly considered to be benign diseases. However, life-threatening weakness episodes or progressive permanent weakness may make these diseases severe, particularly the periodic paralyses (PP). Even in the typical PP forms characterized by episodic occurrence of weakness, up to 60% of the patients suffer from permanent weakness and myopathy with age. In addition, some PP patients present with a predominant progressive muscle weakness phenotype. The weakness can be explained by strongly depolarized fibers that take up sodium and water and that are electrically inexcitable. Drugs that repolarize the fiber membrane can restore muscle strength and may prevent progression.
  • |Anesthetics, Local/therapeutic use[MESH]
  • |Anti-Arrhythmia Agents/therapeutic use[MESH]
  • |Channelopathies/*drug therapy/*genetics[MESH]
  • |Diuretics/therapeutic use[MESH]
  • |Drug Therapy/*trends[MESH]
  • |Humans[MESH]
  • |Myasthenic Syndromes, Congenital/drug therapy/genetics[MESH]
  • |Myotonia/drug therapy/genetics[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box